Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Bicalutamide in China CAS 90357-06-5 Overview and Applications

Sep . 25, 2024 14:51 Back to list

Bicalutamide in China CAS 90357-06-5 Overview and Applications



Bicalutamide, with the CAS number 90357-06-5, is a non-steroidal anti-androgen medication that is primarily used in the treatment of prostate cancer. This pharmaceutical agent plays a crucial role in hormone therapy, specifically in managing conditions characterized by androgen excess. As a competitive antagonist of the androgen receptor, bicalutamide effectively blocks the action of testosterone and other androgens, which are hormones that can promote the growth of prostate cancer cells.


.

The medication is usually administered orally and is available in various forms, including tablets of 50 mg and 150 mg dosages. Patients typically take bicalutamide once daily, and the treatment may continue for several months or even years, depending on the individual’s response and the progression of their disease. The choice of dosage and duration of treatment is tailored to each patient based on specific clinical factors and the severity of their condition.


china bicalutamide cas 90357-06-5

china bicalutamide cas 90357-06-5

While bicalutamide is generally well-tolerated, it can cause some side effects. Common adverse effects include hot flashes, breast tenderness or enlargement, and gastrointestinal disturbances, such as nausea. In some cases, patients may experience more severe reactions, and continuous monitoring by healthcare providers is essential to manage these potential issues effectively.


Beyond prostate cancer, research is ongoing to explore the efficacy of bicalutamide in other conditions influenced by androgens, such as certain forms of breast cancer and hirsutism in women. The expanding therapeutic indications reflect the drug's versatility and the ongoing need for effective anti-androgen therapies.


In summary, bicalutamide (CAS 90357-06-5) represents a significant advancement in the treatment of prostate cancer, showcasing the importance of hormonal therapies in oncology. Its role as a competitive androgen receptor antagonist allows it to effectively inhibit the influences of male hormones that exacerbate cancer progression. With continued research and clinical applications, bicalutamide remains a cornerstone in the fight against prostate cancer, helping countless patients maintain their quality of life and extend their survival.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
smSamoan
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu smSamoan